Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Uwe Schauer

Showing results (11-20 of 15) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 15 results.
Central-European Journal of Immunology|November 12, 2021
A structured patient empowerment programme for primary immunodeficiency significantly improves general and health-related quality of lifeMaria Fasshauer, Gesine Schuermann, Norbert Gebert, et al.
Immunotherapy|July 29, 2024
A patient empowerment program for primary immunodeficiency improves quality of life in children and adolescentsMaria Fasshauer, Gesine Schuermann, Norbert Gebert, et al.
Pediatrics|March 25, 2015
Safety and efficacy of pimecrolimus in atopic dermatitis: a 5-year randomized trialBardur Sigurgeirsson, Andrzej Boznanski, Gail Todd, et al.
Clinical Immunology (Orlando, Fla.)|November 27, 2019
Distinct molecular response patterns of activating STAT3 mutations associate with penetrance of lymphoproliferation and autoimmunitySabine Jägle, Maximilian Heeg, Sarah Grün, et al.
Frontiers in Immunology|August 6, 2019
The German National Registry of Primary Immunodeficiencies (2012-2017)Sabine M El-Helou, Anika-Kerstin Biegner, Sebastian Bode, et al.
Pageof 2

Showing results (11-20 of 15) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 15 results.
Central-European Journal of Immunology|November 12, 2021
A structured patient empowerment programme for primary immunodeficiency significantly improves general and health-related quality of lifeMaria Fasshauer, Gesine Schuermann, Norbert Gebert, et al.
Immunotherapy|July 29, 2024
A patient empowerment program for primary immunodeficiency improves quality of life in children and adolescentsMaria Fasshauer, Gesine Schuermann, Norbert Gebert, et al.
Pediatrics|March 25, 2015
Safety and efficacy of pimecrolimus in atopic dermatitis: a 5-year randomized trialBardur Sigurgeirsson, Andrzej Boznanski, Gail Todd, et al.
Clinical Immunology (Orlando, Fla.)|November 27, 2019
Distinct molecular response patterns of activating STAT3 mutations associate with penetrance of lymphoproliferation and autoimmunitySabine Jägle, Maximilian Heeg, Sarah Grün, et al.
Frontiers in Immunology|August 6, 2019
The German National Registry of Primary Immunodeficiencies (2012-2017)Sabine M El-Helou, Anika-Kerstin Biegner, Sebastian Bode, et al.
Pageof 2